AstraZenca Wins Seroquel Trial (AZN)
A New Jersey state court jury has ruled the Seroquel trial in AstraZenca Plc's (NYSE: AZN) favor. The plaintiff had held its antipsychotic drug Seroquel responsible for causing diabetes. The British company has about 10,400 lawsuits filed against it in U.S. courts. This case was the first one to reach the trial stage.
A spokesperson for AstraZenca (AZN) said, “The heart of these cases are unproven claims that Seroquel causes diabetes in individual plaintiffs. In case after case, jurors, judges and even plaintiffs' lawyers themselves have found that plaintiffs simply cannot show through any accepted scientific method that AstraZeneca is responsible for their alleged injuries."
Seroquel is one of the 10 best-selling drugs in the world.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
